Bioseal Dural Sealing Study BIOS-14-001

Status Completed

Clinical Trial Summary

A Prospective, Randomized, Controlled, Single Blinded, Study to Evaluate the Safety and Effectiveness of Bioseal as an Adjunct to Sutured Dural Repair

Clinical Trial Description

This is a randomized, single blinded, multi-center controlled study evaluating the effectiveness of Bioseal as an adjunct to sutured dural closure compared to control to obtain an intra-operative watertight dural closure. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03110783
Study type	Interventional
Source	Guangzhou Bioseal Biotechnology Co., Ltd.
Contact
Status	Completed
Phase	Phase 3
Start date	September 14, 2017
Completion date	September 20, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02041871` - Interest of PReOPerative Immunonutrition in Liver Surgery for Cancer	N/A
Recruiting	`NCT05516914` - A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors	Phase 1/Phase 2
Completed	`NCT02534506` - Study of Urelumab in Subjects With Advanced and/or Metastatic Malignant Tumors	Phase 1
Recruiting	`NCT05714748` - Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors	Phase 1
Recruiting	`NCT05987098` - BBPA PET/CT in Patients With Malignant Tumors	N/A
Not yet recruiting	`NCT01092247` - The Effect of Ketogenic Diet on Malignant Tumors- Recurrence and Progress	N/A
Recruiting	`NCT03160599` - Restricted Calorie Ketogenic Diet as a Treatment in Malignant Tumors	N/A
Recruiting	`NCT04702841` - CAR - γ δ T Cells in the Treatment of Relapsed and Refractory CD7 Positive T Cell-derived Malignant Tumors	Early Phase 1
Completed	`NCT00165100` - Dynamic Area Telethermometry (DAT) as an Imaging Modality in Patients With Cancer	N/A
Suspended	`NCT05615974` - A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors	Phase 1/Phase 2
Completed	`NCT03542773` - Targeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PET	Phase 1
Completed	`NCT05293990` - Usefulness of Gadovist-enhanced FLAIR Imaging	N/A
Completed	`NCT01509612` - Additive Homeopathy in Cancer Patients	Phase 3
Completed	`NCT01678690` - An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors	Phase 0
Suspended	`NCT06270394` - FAP PET/CT or PET/MR Production in the Diagnosis, Staging, and Efficacy Assessment of Malignant Tumors Application	N/A
Completed	`NCT00412503` - Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and Adolescents	Phase 1